Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1159 of 5804
-
New immune cell therapy takes on tough lung cancer
Disease control Recruiting nowThis is a single-arm, open-label, dose-escalation clinical trial designed to evaluate the safety, tolerability, expansion, and persistence of TC-D101 CAR-T cells in patients with DLL3-positive Relapsed/Refractory primary small cell lung cancer(r/r SCLC) who have progressed after …
Phase: EARLY_PHASE1 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New coil procedure aims to stop brain clots from returning
Disease control Not yet recruitingAll participants will be asked to have a minimally invasive procedure for the treatment of chronic subdural hematoma, a blood clot on the brain. Depending on the specific condition patients may also have a surgical procedure, a mini-craniotomy or burr holes where the skull is pie…
Sponsor: Kaneka Medical America LLC • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New eczema pill shows promise in large Real-World trial
Disease control Not yet recruitingAtopic dermatitis (AD) is a skin condition characterized by a rash and itching, resulting from skin inflammation. Ivarmacitinib is an approved medication for treating AD. This study aims to evaluate the effectiveness and safety of Ivarmacitinib in the treatment of moderate-to-se…
Phase: NA • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Quince and acupressure put to the test against morning sickness
Symptom relief CompletedNausea and vomiting during pregnancy are common, affecting a large proportion of women (approximately 50-75%). This symptom usually begins in the first trimester and is mostly mild or moderate; however, in some cases, it impairs quality of life, reduces nutritional intake, leads …
Phase: NA • Sponsor: Antalya Bilim University • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
AI eye doctor: new study aims to spot Blindness-Causing diseases faster
Diagnosis Not yet recruitingThis observational study aims to establish key technologies for high-throughput, large-model-based AI-assisted diagnosis using optical coherence tomography (OCT) and OCT angiography (OCTA). The study will collect real-world OCT/OCTA images and corresponding clinical information f…
Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
ER nurse chat could save babies from sleep death
Prevention Not yet recruitingThe sudden unexpected infant death (SUID) is defined as "the sudden death of a child aged from 1 month to 1 year who had been healthy until then, whereas nothing in his known history or in the history of events could have allowed him to predict". In France, the French High Autori…
Sponsor: University Hospital, Angers • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC
-
New Dual-Action drug targets Hard-to-Treat tumors
Disease control Recruiting nowStage 1 (Safety study for 68Ga-NRT6020 Injection): The goal of this clinical trial stage is to evaluate the safety of 68Ga-NRT6020 Injection in participants with advanced solid tumors. The study will also assess the biodistribution, radiation dosimetry, imaging profile, and phar…
Phase: PHASE1 • Sponsor: Chengdu New Radiomedicine Technology Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug aims to tackle diabetes by targeting stress hormone
Disease control Recruiting nowCAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated cortisol risk factors for trial eligibility and the presence of elevated cortisol. Participants deemed eligible from Part 1 will be randomized to either clofutrib…
Phase: PHASE2 • Sponsor: Sparrow Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New HIV pill CL-197 shows promise in early trial for untreated patients
Disease control Recruiting nowThis study will evaluate the antiretroviral activity, safety and pharmacokinetics of single dose of CL-197 capsule in three dose groups administered to antiretroviral treatment-naïve adult participants with human immunodeficiency virus type 1 (HIV-1) infection.
Phase: PHASE2 • Sponsor: Henan Genuine Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New chemo combo targets cancer belly fluid in early trial
Disease control Recruiting nowThis study is a prospective, multi-cohort Phase Ib/II clinical trial, consisting of two stages as follows: 1. Phase Ib Dose-Escalation Stage To explore the dose-limiting toxicities (DLT) of intraperitoneally administered liposomal irinotecan in patients with malignant peritoneal…
Phase: PHASE1, PHASE2 • Sponsor: Dong sheng Zhang • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could a gentle brain ZAP help ALS patients breathe easier?
Symptom relief Recruiting nowAmyotrophic Lateral Sclerosis (ALS) is a nervous system disease that causes muscle weakness and rapidly progresses to the loss of mobility and functionality. Studies suggest that High-Definition Transcranial Direct Current Stimulation (HD-tDCS) is a technique for modulating motor…
Phase: PHASE2, PHASE3 • Sponsor: Universidade Federal do Rio Grande do Norte • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Magnetic pulses to the brain may offer rapid relief from prolonged grief
Symptom relief Recruiting nowGrief is a normal response after the death of a loved one. With time, the grief response decreases and people learn to cope with their loss. However, for some, the response becomes more intense and distressing. This is called prolonged grief disorder (PGD). People with PGD experi…
Phase: NA • Sponsor: Bruyère Health Research Institute. • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
New ultrasound technique could spot brain disorders in babies before symptoms appear
Knowledge-focused Recruiting nowNeurodevelopmental disorders (NDD) affect how the brain develops and can lead to lifelong difficulties with movement, learning, behavior, and thinking. Every year, around one million newborns in Europe are affected by these conditions. Some babies are at higher risk of NDD due to…
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
New hope for early MS: Twice-Yearly infusion trial launches
Disease control Recruiting nowIn this prospective, open-label, single-arm, single-institution trial, the investigators will accomplish the following two aims: 1. study the safety and tolerability of Ublituximab (Briumvi) twice annually in participants with early MS over a treatment observation period of \~12…
Phase: PHASE4 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Scientists hunt for genetic clues behind rare blood disorders
Knowledge-focused Recruiting nowBy detailed sequence analysis and subsequent biophysical characterization of prototypic light chains, this project aims to identify sequence fingerprints in IGLV1-44 light chains leading to AL amyloidosis and POEMS syndrome. This understanding might help improve the risk stratifi…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Can tackling stigma help end HIV? new study tests a dual approach
Disease control OngoingThe overall goal of the Ssinga Nze study ("Ssinga Nze" means "If it were me" in Luganda, the local language) is to reduce HIV-related stigma and improve access to HIV care, including antiretroviral treatment (ART) and HIV pre-exposure prophylaxis (PrEP), as well as increase linka…
Phase: NA • Sponsor: Makerere University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New pill could stop the maddening itch of prurigo nodularis
Symptom relief Recruiting nowEvaluate the efficacy and safety of ICP-332 in participants with Prurigo Nodularis (PN)
Phase: PHASE2 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New hope for Platinum-Resistant ovarian cancer?
Disease control Recruiting nowOvarian cancer (OC) is a lethal disease. The purpose of this study is to assess the safety, pharmacokinetics and efficacy of ABBV901, alone or in combination with bevacizumab, in participants with ovarian cancer. ABBV901 is an investigational drug for the treatment of ovarian ca…
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New catheter aims to clear small brain clots in stroke patients
Disease control Recruiting nowProspective, Single-arm, Multi-centre Study to Evaluate the Efficacy and Safety of the iNstroke 4F Thromboaspiration Catheter in Patients with Acute Ischaemic Stroke due to Primary Distal Medium Vessel Occlusions.
Phase: NA • Sponsor: iVascular S.L.U. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug MHB042C tested in advanced cancer patients
Disease control Recruiting nowThis is a first-in-human, open-label, multicenter Phase I/II study of MHB042C in patients with advanced solid tumors. The study was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of MHB042C monotherapy.
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC